Clinical Trials Logo

Filter by:
  • Terminated  
  • « Prev · Page [23]
NCT ID: NCT00057382 Terminated - Clinical trials for Hepatocellular Carcinoma

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Start date: March 2003
Phase: Phase 2/Phase 3
Study type: Interventional

This is an international, multicenter, randomized study of intravenous T138067 versus intravenous doxorubicin in hepatocellular carcinoma (liver cancer). Patients can not have been treated before with chemotherapy and surgery is not recommended for their cancer. A total of 750 subjects will be enrolled in this study.

NCT ID: NCT00040404 Terminated - Parkinson Disease Clinical Trials

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease

Start date: March 2002
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to establish safety for CEP-1347 and to determine an efficacious dose in the treatment of Parkinson's disease.

NCT ID: NCT00036205 Terminated - Parkinson Disease Clinical Trials

Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

Start date: August 2000
Phase: Phase 3
Study type: Interventional

The primary objective is to assess the long term safety and tolerability of sumanirole as measured by safety labs, ECG monitoring, vital signs, and adverse event reports in subjects with Parkinson's Disease who participated in previous sumanirole studies.

NCT ID: NCT00032084 Terminated - Lung Cancer Clinical Trials

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

Start date: January 2002
Phase: Phase 3
Study type: Interventional

RATIONALE: A program that includes bupropion may be more effective in helping early-stage lung cancer patients to quit smoking. It is not yet known if a program to quit smoking is more effective with or without bupropion. PURPOSE: Randomized phase III trial to determine the effectiveness of a program to quit smoking with or without bupropion in treating patients who have undergone surgery for stage I or stage II non-small cell lung cancer.

NCT ID: NCT00028067 Terminated - HIV Infections Clinical Trials

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

Start date: August 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the atazanavir and nelfinavir (NFV) treatments in their ability to reduce viral load.

NCT ID: NCT00009906 Terminated - Clinical trials for Gastrointestinal Stromal Tumor

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Start date: December 2000
Phase: Phase 3
Study type: Interventional

Randomized phase III trial to compare the effectiveness of two different doses of STI571 in treating patients who have metastatic or unresectable gastrointestinal stromal tumor. STI571 may interfere with the growth of tumor cells and may be an effective treatment for cancer. It is not yet known which dose of STI571 is more effective in treating gastrointestinal stromal tumors.

NCT ID: NCT00003292 Terminated - Chondrosarcoma Clinical Trials

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Start date: July 1998
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with meningeal tumors that have recurred or that cannot be removed surgically.

NCT ID: NCT00002668 Terminated - Breast Cancer Clinical Trials

Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer

Start date: February 14, 1996
Phase: N/A
Study type: Interventional

RATIONALE: An outpatient educational and behavioral skills training program may help patients with metastatic breast or prostate cancer live longer and more comfortably. PURPOSE: This randomized clinical trial studies whether an outpatient educational and behavioral skills training program will improve pain control in patients who have metastatic or recurrent breast or prostate cancer.